SCHEMBL13508156

SCHEMBL13508156

Cn1c2cc(N(c3ccccc3)c3ccc(-c4ccccc4)cc3)ccc2c2c3ccccc3c3c4ccc(N(c5ccccc5)c5ccc(-c6ccccc6)cc5)cc4n(C)c3c21

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ LIMK1 P53667 1/20 0.43
▸ MAOB P27338 1/20 0.43
▸ RXRA P19793 1/20 0.36
▸ RXRB P28702 1/20 0.36
▸ KDM4E B2RXH2 2/20 0.36
▸ MAPT P10636 1/20 0.36
▸ AXL P30530 1/20 0.35
▸ GABRP O00591 1/20 0.35
▸ GABRD O14764 1/20 0.35
▸ GABRA1 P14867 1/20 0.35
▸ GABRB1 P18505 1/20 0.35
▸ GABRG2 P18507 1/20 0.35
▸ GABRB3 P28472 1/20 0.35
▸ GABRA5 P31644 1/20 0.35
▸ GABRA3 P34903 1/20 0.35
▸ GABRA2 P47869 1/20 0.35
▸ GABRB2 P47870 1/20 0.35
▸ GABRA4 P48169 1/20 0.35
▸ GABRE P78334 1/20 0.35
▸ GABRA6 Q16445 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18564837 0.95 MAOB (0.41) LIMK1MAOBRXRARXRBKDM4E
SCHEMBL13507879 0.94 KDM4E (0.39) LIMK1MAOBKDM4EMAPTGABRP
SCHEMBL13507627 0.93 LIMK1 (0.47) LIMK1MAOBRXRARXRBKDM4E
SCHEMBL18564914 0.90 MAOB (0.40) LIMK1MAOBRXRARXRBKDM4E
SCHEMBL18564842 0.89 MAOB (0.47) LIMK1MAOBRXRARXRBKDM4E
SCHEMBL18564873 0.89 MAOB (0.47) LIMK1MAOBRXRARXRBKDM4E
SCHEMBL13507560 0.89 TP53 (0.39) KDM4EMAPTGABRPGABRDGABRA1
SCHEMBL18564752 0.89 KDM4E (0.37) LIMK1MAOBKDM4EMAPTGABRP
SCHEMBL18564905 0.89 MAOB (0.44) LIMK1MAOBRXRARXRBKDM4E
SCHEMBL18564907 0.89 MAOB (0.44) LIMK1MAOBRXRARXRBKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100032658-A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same GRACEL DISPLAY INC. (KR) 2010-02-11 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100032658-A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same OCIAD1, OCIAD2, ORMDL3 LIMK1 222/4885MAOB 446/4885RXRA 3214/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback